News
Shares of the Ozempic-maker fell while the rest of the market rose,as it's facing a hit to revenue from different directions.
Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...
Company Announcement No. 9/2025 Copenhagen, 15 May 2025 Scandinavian Tobacco Group A/S – Reduction of share capital On 9 April 2025, the annual general meeting of Scandinavian Tobacco Group A/S (the ...
We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Kontra Investments. In this article, we will ...
Vestas Wind Systems faces challenges like geopolitical risks and competition. Find out why its valuation drop may not make it ...
A Twitch streamer has been fined for promoting unlicensed gambling sites by the Danish authorities. Here’s what we know.
Investing.com -- Lundbeck (CSE: HLUNb) on Wednesday raised its full-year revenue and earnings guidance after reporting a 16% increase in first-quarter revenue at constant exchange rates to DKK 6.24 ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
Sir Keir Starmer’s claim that the UK risked becoming an “island of strangers” unless it introduced stricter immigration ...
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.
Torm shares rose as much as 6% in Copenhagen after Pareto Securities upgraded to buy from hold. Head of research Eirik ...
18h
TipRanks on MSNDemant price target lowered to DKK 310 from DKK 325 at Morgan StanleyMorgan Stanley lowered the firm’s price target on Demant (WILYY) to DKK 310 from DKK 325 and keeps an Overweight rating on the shares. Published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results